Global Protein Therapeutics Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Protein Therapeutics Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Protein Therapeutics Drugs are a type of medicine that are used to treat a variety of diseases such as cancer, metabolic, immunological, hematological, hormonal, genetic, infectious diseases, and others. These drugs have the potential to significantly improve human health. In principle, protein therapy is similar to gene therapy; which involves protein delivery in specific amounts to the body to facilitate precise functioning of different glands and other organs in the body



According to our (Global Info Research) latest study, the global Protein Therapeutics Drugs market size was valued at US$ 299420 million in 2023 and is forecast to a readjusted size of USD 489940 million by 2030 with a CAGR of 7.1% during review period.

Growth of the protein therapeutics market is majorly driven by rise in prevalence of chronic diseases and development of plasma-derived therapies. Increase in prevalence of various diseases such as cancer, metabolic disorders, genetic disorders, and immunological diseases are expected to propel demand for protein therapeutics. In addition, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and cancer cases are expected to increase significantly in the future. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market.

This report is a detailed and comprehensive analysis for global Protein Therapeutics Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Protein Therapeutics Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030

Global Protein Therapeutics Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030

Global Protein Therapeutics Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030

Global Protein Therapeutics Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Protein Therapeutics Drugs

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Protein Therapeutics Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson, Pfizer Inc, F. Hoffmann La Roche Ltd, Novo Nordisk AS, Sanofi, Amgen Inc, Merck and Co., Inc, Abbott Laboratories, Baxter International Inc, Eli Lilly And Company, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Protein Therapeutics Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Monoclonal Antibodies
Insulin
Fusion Protein
Erythropoietin
Interferon
Human Growth Hormone
Others

Market segment by Application
Cancer
Metabolic Disorders
Immunologic Disorders
Hematological Disorders
Hormonal Disorders
Genetic Disorders
Others

Major players covered
Johnson and Johnson
Pfizer Inc
F. Hoffmann La Roche Ltd
Novo Nordisk AS
Sanofi
Amgen Inc
Merck and Co., Inc
Abbott Laboratories
Baxter International Inc
Eli Lilly And Company
AbbVie
Novartis
Gilead Sciences
Bristol-Myers Squibb
Innovent
AstraZeneca
Hengrui Medicine
Takeda
Kanghong Pharma
Seagen
Sobi

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Protein Therapeutics Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Protein Therapeutics Drugs, with price, sales quantity, revenue, and global market share of Protein Therapeutics Drugs from 2019 to 2024.

Chapter 3, the Protein Therapeutics Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Protein Therapeutics Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Protein Therapeutics Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Protein Therapeutics Drugs.

Chapter 14 and 15, to describe Protein Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion.